Scientists Unlock a Game-Changing Way to Turn Plastic Waste Into Medicine

A groundbreaking new study from the University of Edinburgh has revealed a pioneering method to turn waste plastic bottles into L-DOPA, a frontline treatment for Parkinson’s disease. The researchers engineered E. coli bacteria to convert polyethylene terephthalate, commonly used in food packaging, into this vital pharmaceutical.

This biological breakthrough offers a more sustainable alternative to drug manufacturing, which typically depends on finite fossil fuels. By reimagining plastic waste as a valuable carbon source, this technology addresses both environmental pollution and human health needs.

“If we can create medicines for neurological disease from a waste plastic bottle, it’s exciting to imagine what else this technology could achieve,” said Dr. Stephen Wallace.

“Plastic waste is often seen as an environmental problem, but it also represents a vast, untapped source of carbon.”

Quick Smiles:

• The process converts terephthalic acid from recycled PET into medicine through biological reactions.
• L-DOPA is a critical precursor for neurotransmitters like dopamine and also treats Restless Leg Syndrome.
• The research was supported by a new hub dedicated to converting industrial waste into sustainable materials.

“By converting discarded plastic into a treatment for Parkinson’s disease, the University of Edinburgh team has demonstrated how carbon can be turned into high value products that improve lives,” stated Professor Charlotte Deane.

The team is currently working to scale this technology for industrial use while optimizing its environmental performance. This innovation proves that with creative engineering, society’s most pressing challenges can be solved by rethinking the value of discarded materials.

Source